Your session is about to expire
← Back to Search
Time Restricted Eating During Chemotherapy for Breast Cancer
Study Summary
This trialwill study if time-restricted eating can help improve cancer treatment and reduce side effects. #BreastCancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a stroke.I have been diagnosed with congestive heart failure.I have cirrhosis.You use illegal drugs or drink more than 2 alcoholic drinks per day.I do not have uncontrolled HIV/AIDS or active hepatitis.My blood tests show my organs are working well.My breast cancer is confirmed to be at Stage I, II, or III.I have chronic pancreatitis.I have had a solid organ transplant.I am between 25 and 99 years old.I have had a heart attack.I have chronic hepatitis.I am a woman with either metastatic disease or type 1 or 2 diabetes.If you have lost or gained a lot of weight in the last 3 months (more than 4 kilograms), you cannot participate in the study.I have a history of eating disorders.I am mentally and physically able to participate in a clinical trial.People who work night shifts.My BMI is between 25 and 40.I am fully active or can carry out light work.I understand and can follow the study's procedures.You are currently in a weight loss program like Weight Watchers.I am currently on medication for an infection.I don't have any other cancers that could affect this treatment's safety or results.
- Group 1: Time restricted eating
- Group 2: Med TRE
- Group 3: Standard care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are any slots available for potential participants in this experiment?
"Affirmative. Per the information listed on clinicaltrials.gov, this trial is presently recruiting participants. It was first revealed on August 1st 2022 and updated lastly November 30th 2022; 40 individuals will be welcomed from a single location."
Do I have the required qualifications to participate in this medical research?
"This clinical trial is currently seeking 40 individuals aged between 25 and 99 that have been diagnosed with a neoplasm. The eligibility requirements are as follows: Aged 25-99 at time of consent, ECOG 0 or 1, Breast cancer to meet histologically confirmed Stage I-III., Adequate organ function (absolutely neutrophil count ≥ 1,500/μL)., All screening labs must be taken within 30 days prior to registration., Ability to comprehend and adhere to protocol requirements for the entirety of the study period., Provide written informed consent and HIPAA authorization for release of personal health information via an approved UIC Institutional"
What is the maximum capacity of enrollees for this research?
"Affirmative. According to the information on clinicaltrials.gov, this medical trial is presently in its recruitment phase which began August 1st 2022 and was last updated November 30th 2022. A total of 40 patients are needed from one specific centre for participation."
Is the enrollment criterion for this investigation restricted to people below a certain age?
"This medical study is searching for individuals aged 25 and above, but under 99 years old."
Share this study with friends
Copy Link
Messenger